Fig. 1From: Induction of CYP3A activity by dexamethasone may not be strong, even at high doses: insights from a case of tacrolimus co-administrationClinical course of the present patient. The doses of APR, DEX and TAC; TAC C/D ratio; and laboratory parameters are shown. APR, aprepitant; DEX, dexamethasone; TAC, tacrolimus; TAC C/D ratio: TAC trough blood concentration/dose ratio; LDH, lactate dehydrogenase; ALT, alanine aminotransferaseBack to article page